ITGA2 and neoplasm: Previous studies reported that the carcinogenic mechanism of ITGA2 is rarely involved in pancreatic cancer, except that blocking ITGA2 can improve tumor immune response by reducing the phosphorylation level of STAT3 and inhibiting the PD-L1 expression [10].